UnknownNot Applicable

Clinical Performance of Composites in Patients With Amelogenesis Imperfecta

15 participantsStarted 2014-09-02

Plain-language summary

In AI patients, adhesion still remains the first option in order to achieve an early, minimally invasive intervention, and the altered enamel still represents an acceptable substrate for bonding in some AI variants. Many cases have revealed that the direct composite restorations provide satisfactory esthetic and functionality in restoring AI-affected teeth. The objective of this study was to evaluate the clinical performance of composite restorations in posterior teeth in patients afflicted with Amelogenesis Imperfecta using nanohybrid and nanofill composite materials

Who can participate

Age range14 Years – 30 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * the patient had to require treatment due to carious lesions in one or more surface of molars and premolars, * AI diagnosis had to be made, which had to be verified clinically, and also confirmed by anamnestic family history, or clinical examination concerning Witkop's classification Exclusion Criteria: * patients with developmental enamel defects of other origins such as fluorosis, molar incisor hypomineralization; * AI was associated with other oral developmental or systemic disorders, and dental abnormalities such as open-bite, deep-bite, and cross-bite; * patients who were unable to provide their informed consent.

What they're measuring

Number of failed restorations evaluated according to the modified USPSH criteria in patients with occlusal restorations.

Timeframe: an average of 1 year

Trial details

NCT IDNCT04897724

SponsorNeslihan Tekçe

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-09-19

View on ClinicalTrials.gov More Amelogenesis Imperfecta trials